oral semaglutide efficacy and safety of once-daily 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial Safety and efficacy of oral

To evaluate the potential of different pathways geared toward improving GSH synthesis, several DNA-mediated integrative expression vectors pGAPh-gsh2gsh1, pGAPg-pro1gshB or pGAPg-proBgshB harbouring different pathway genes were constructed

The Summary of Product Characteristics (SmPC) for these medications provides guidance on their use in various patient populations, emphasising individualised risk assessment before initiating treatment

Noom Microdose GLP-1 Rx Program is designed to stay at a lower dose to help reduce side effects while still supporting meaningful weight loss

reported a patient with a homozygous LOF MC4R variant (p.Arg165Gln) who initially lost 40 kg following Roux-en-Y gastric bypass but subsequently regained all lost weight [68]

Methods 29 (9), 644653